Project Orbis: Implications for Access and Pricing in the UK
Published on February 22, 2021
Project Orbis: Implications for Access and Pricing in the UK
Rachel Pope
Mon, 02/22/2021 - 08:13pm
Body
Post-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments. This article looks at the implications of Project Orbis for commercialization in the UK and the key considerations for industry in considering the project as a pathway.